A detailed history of Td Asset Management Inc transactions in Generation Bio Co. stock. As of the latest transaction made, Td Asset Management Inc holds 340,686 shares of GBIO stock, worth $405,416. This represents 0.0% of its overall portfolio holdings.

Number of Shares
340,686
Previous 340,686 -0.0%
Holding current value
$405,416
Previous $960,000 12.4%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$0.91 - $3.35 $59,979 - $220,805
-65,912 Reduced 16.21%
340,686 $562,000
Q3 2023

Oct 27, 2023

BUY
$3.65 - $6.9 $621,751 - $1.18 Million
170,343 Added 72.1%
406,598 $1.54 Million
Q2 2023

Aug 09, 2023

BUY
$3.5 - $5.67 $16,779 - $27,181
4,794 Added 2.07%
236,255 $1.3 Million
Q3 2022

Nov 07, 2022

BUY
$4.68 - $8.34 $100,620 - $179,310
21,500 Added 10.24%
231,461 $1.18 Million
Q1 2022

May 10, 2022

SELL
$4.16 - $7.76 $115,065 - $214,641
-27,660 Reduced 11.64%
209,961 $1.54 Million
Q4 2021

Feb 10, 2022

BUY
$5.99 - $24.97 $289,203 - $1.21 Million
48,281 Added 25.5%
237,621 $1.68 Million
Q3 2021

Nov 09, 2021

BUY
$20.0 - $27.43 $228,500 - $313,387
11,425 Added 6.42%
189,340 $4.75 Million
Q2 2021

Aug 11, 2021

BUY
$24.34 - $38.34 $498,337 - $784,973
20,474 Added 13.0%
177,915 $3.87 Million
Q1 2021

May 14, 2021

BUY
$24.74 - $40.2 $1.23 Million - $1.99 Million
49,560 Added 45.94%
157,441 $4.48 Million
Q4 2020

Feb 16, 2021

BUY
$21.68 - $51.61 $1.78 Million - $4.24 Million
82,063 Added 317.85%
107,881 $3.06 Million
Q3 2020

Nov 10, 2020

BUY
$18.07 - $31.84 $41,561 - $73,232
2,300 Added 9.78%
25,818 $798,000
Q2 2020

Aug 13, 2020

BUY
$20.1 - $24.69 $472,711 - $580,659
23,518 New
23,518 $494,000

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $70.2M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.